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Murine leukemia viruses (MuLVs) encode an alternate
form of Gag protein in addition to the standard Gag pre-
cursor polyprotein, glycosylated Gag (glyco-gag or
gPr80
gag). gPr80
gag contains additional amino-terminal
peptides, and it is glycosylated. Until recently the func-
tion of gPr80
gag was unclear, but we have recently shown
that gPr80
gag facilitates viral budding and release through
lipid rafts. Glyco-gag mutant virus is less efficiently
released from fibroblasts, mutant virus has lower choles-
terol content (and higher buoyant density), and less Gag
precursor polyprotein (Pr65
gag) is associated with deter-
gent-resistant membranes in infected cells. The mechan-
ism by which gPr80
gag facilitates virus release is under
investigation. The N-terminal 88 amino acids of gPr80
gag
are sufficient to enhance virus release, indicating that the
Gag sequences on this protein are not required. Cellular
La protein is involved in gPr80
gag function, since over-
expression of La phenocopies gPr80
gag in facilitating
virus release, and knockdown of La abrogates gPr80
gag-
enhancement of virus release. MuLV glyco-gag can also
facilitate release of HIV-1 particles from transfected cells,
which suggests that these two viruses may share mechan-
isms for directing virus release through lipid rafts.
gPr80
gagalso counteracts the murine APOBEC3 restric-
tion factor (mA3) since gPr80
gagmutant virus shows a
defect for establishment of infection in wild-type mice,
but not in mA3 knockout animals.
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